Lv4
460 积分 2024-10-22 加入
Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A
11天前
已完结
Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling
13天前
已完结
[Prediction of the pharmacokinetic drug-drug interaction of pravastatin and pitavastatin with cyclosporine by a digital liver model based on metabolism and transporter]
22天前
已完结
Incorporation and Performance Verification of Hepatic Portal Blood Flow Shunting in Minimal and Full PBPK Models of Liver Cirrhosis
29天前
已完结
CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics
1个月前
已关闭
The Bioequivalence Between Valsartan Oral Solution and Suspension Formulations Developed for Pediatric Use
1个月前
已完结
Pharmacokinetics of anti-TB drugs in children and adolescents with drug-resistant TB: a multicentre observational study from India
1个月前
已完结
Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis of Second-Line Anti-Tubercular Drugs in Indian Children with Multi-Drug Resistance
1个月前
已完结
Challenges and potential solutions for cycloserine dosing in patients with sepsis undergoing continuous renal replacement therapy
1个月前
已完结
Simultaneous determination and pharmacokinetics study of valsartan, sacubitril and its major metabolite in human plasma, urine and peritoneal dialysis fluid in patients with end-stage renal disease by UPLC–MS/MS
1个月前
已完结
皖公网安备34019202002308
